- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01831362
Dismantling Mindfulness: Contributions of Attention vs. Acceptance
This study addresses NCCAM's request for research that investigates the neuropsychological mechanisms underlying mind-body therapies, and for precise criteria and better delineation of meditation practices.
The purpose of this study is to assess the clinical efficacy and mechanism of action of 2 component practices of "mindfulness meditation", i.e. focused awareness (FA) and open monitoring (OM) in comparison to each other and to the standard package, Mindfulness-Based Cognitive Therapy (MBCT).
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02912
- Brown University Clinical and Affective Neuroscience Laboratory
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- English-speaking
- ages 18-65
- mild-severe levels of depression or high level of negative affect
Exclusion Criteria:
Current:
- age <18 or >65
- inability to read and write in English
- Extremely severe levels of depression
- active suicidal ideation
- presence of Axis I personality disorder
- panic disorder
- post-traumatic stress disorder
- obsessive-compulsive disorder
- eating disorder, or substance abuse/dependence
- current psychotherapy
- change in antidepressant medication type or dosage in the last 8 weeks.
Lifetime history exclusions:
- bipolar disorder
- psychotic disorders
- persistent antisocial behavior or repeated self-harm,
- borderline personality disorder,
- organic brain damage
- regular meditation practice
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Focused Attention (FA)
This 8 week program consists solely of focused attention practices, i.e. selected attention to an object (breath etc) and deselection of other stimuli
|
|
Experimental: Open-Monitoring (OM)
This 8-week program consists solely of open monitoring practices, or noticing and/or labeling the contents of ongoing experience ( thoughts, body sensations, emotions, seeing, hearing etc) without focusing on or deselecting any stimuli
|
|
Experimental: Mindfulness-Based Cognitive Therapy (MBCT)
The 8 week MBCT program follows the 2nd Edition (2012) manual (Segal, Williams, Teasdale) and includes both focused attention and open- monitoring practices
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Inventory of Depressive Symptomatology
Time Frame: baseline, 8 weeks, 20 weeks
|
30-item clinician administered interview about unipolar depression symptoms
|
baseline, 8 weeks, 20 weeks
|
change in Depression, Anxiety Stress Scale (DASS)
Time Frame: baseline, week 2,4,6,8, 20
|
42-item self-report questionnaire on depression, anxiety and stress symptoms
|
baseline, week 2,4,6,8, 20
|
change in Wellbeing Scale (WBS)
Time Frame: baseline, 8 weeks, 20 weeks
|
73-item self-report questionnaire of psychological wellbeing
|
baseline, 8 weeks, 20 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in alpha-theta EEG power from baseline to 8 weeks
Time Frame: baseline and 8 weeks
|
Resting/spontaneous EEG power in 5-9 Hz range
|
baseline and 8 weeks
|
Change in Facial EMG power from baseline to 8 weeks
Time Frame: baseline and 8 weeks
|
Facial EMG response to emotional (IAPS) photos (reactivity + regulation)
|
baseline and 8 weeks
|
Sustained Attention to response Task (SART)
Time Frame: baseline, 8 weeks
|
40 minuted sustained attention, go-no-go task
|
baseline, 8 weeks
|
Difficulties in Emotion Regulation Scale (DERS)
Time Frame: baseline, 8 weeks, 20 weeks
|
36-item self report of emotion regulation
|
baseline, 8 weeks, 20 weeks
|
Attention Control Questionnaire (Derryberry & Reed, 2002)
Time Frame: baseline, 8 weeks, 20 weeks
|
20-item self report measure of attentional abilities
|
baseline, 8 weeks, 20 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Five Facet Mindfulness Questionnaire (FFMQ)
Time Frame: baseline, week 3,5,7,8,20
|
39-item self-report questionnaire of mindfulness skill acquisition (attention, non-reactivity)
|
baseline, week 3,5,7,8,20
|
Self-Compassion Scale (Neff 2003)
Time Frame: baseline, 8 weeks, 20 weeks
|
26-item self report of attitudes towards oneself
|
baseline, 8 weeks, 20 weeks
|
Positive and Negative Affect Scale (PANAS)
Time Frame: week 1,2,3,4,5,6,7,8
|
60-item self report of emotional states
|
week 1,2,3,4,5,6,7,8
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Cullen B, Eichel K, Lindahl JR, Rahrig H, Kini N, Flahive J, Britton WB. The contributions of focused attention and open monitoring in mindfulness-based cognitive therapy for affective disturbances: A 3-armed randomized dismantling trial. PLoS One. 2021 Jan 12;16(1):e0244838. doi: 10.1371/journal.pone.0244838. eCollection 2021.
- Canby NK, Eichel K, Peters SI, Rahrig H, Britton WB. Predictors of Out-of-Class Mindfulness Practice Adherence During and After a Mindfulness-Based Intervention. Psychosom Med. 2021 Jul-Aug 01;83(6):655-664. doi: 10.1097/PSY.0000000000000873.
- Britton WB, Davis JH, Loucks EB, Peterson B, Cullen BH, Reuter L, Rando A, Rahrig H, Lipsky J, Lindahl JR. Dismantling Mindfulness-Based Cognitive Therapy: Creation and validation of 8-week focused attention and open monitoring interventions within a 3-armed randomized controlled trial. Behav Res Ther. 2018 Feb;101:92-107. doi: 10.1016/j.brat.2017.09.010. Epub 2017 Sep 28.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K23AT006328-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild-moderate Unipolar Depression; Persistent Negative Affect
-
University Hospital, MontpellierAssistance Publique - Hôpitaux de Paris; University Hospital, Clermont-Ferrand and other collaboratorsRecruitingUnipolar Depressed Outpatients | Mild Severity | Without Psychotic FeaturesFrance
-
University of SussexUniversity of California, San Francisco; Brighton & Sussex Medical School; Sylff...CompletedStress | Anxiety | Depressive Symptoms | Positive Affect | Sleep-Related Impairment | Mental Wellbeing | Negative AffectUnited Kingdom
-
King's College LondonKings Health PartnersCompletedDepression | Depressive Disorder, Major | Depression, Unipolar | Depression ModerateUnited Kingdom
-
Norwegian Institute of Public HealthGöteborg University; University of Bergen; The Research Council of Norway; Sussex...Completed
-
Irmandade da Misericórdia de Albergaria-a-VelhaCompletedAnxiety Depression (Mild or Not Persistent)
-
Norwegian Institute of Public HealthGöteborg University; University of Bergen; University of Tromso; Sussex Partnership... and other collaboratorsRecruitingAnxiety | Mild to Moderate DepressionNorway
-
Annecto LLCHoly Redeemer HospitalTerminatedMild to Moderate DepressionUnited States
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Federal Research Center of Fundamental and Translational...CompletedDepression Moderate | Depression MildRussian Federation
-
University of California, San FranciscoNot yet recruitingDepression Moderate | Depression MildUnited States
Clinical Trials on Focused Attention (FA)
-
University of FloridaFlorida Department of HealthCompletedHead & Neck CancerUnited States
-
Université de Reims Champagne-ArdenneRecruiting
-
Western University, CanadaCompleted
-
Sun Life Financial Movement Disorders Research...Canadian Institutes of Health Research (CIHR); Parkinson Society Canada; Canada... and other collaboratorsUnknown
-
Taipei Medical UniversityRecruiting
-
Sun Life Financial Movement Disorders Research...Completed
-
Universiti Putra MalaysiaUMC Utrecht; Ministry of Health, MalaysiaCompletedType 2 Diabetes Mellitus
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); University of California, BerkeleyCompletedAttention Deficit Disorder With HyperactivityUnited States
-
Eunice Kennedy Shriver National Institute of Child...Medical Research Council, South AfricaCompletedHIV | Substance Abuse | ViolenceSouth Africa
-
Matthew J O'Brien, PhD, BCBA-DNational Institute of Mental Health (NIMH); Emory University; University of Houston and other collaboratorsCompletedAutism Spectrum DisorderUnited States